Venus Concept, Inc. (VERO)
0.3105
0.00 (0.00%)
USD |
OTCM |
Apr 07, 16:00
Venus Concept Net Income (Quarterly) : -22.55M for Sept. 30, 2025
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2025 | -22.55M |
| June 30, 2025 | -11.74M |
| March 31, 2025 | -12.37M |
| December 31, 2024 | -8.016M |
| September 30, 2024 | -9.302M |
| June 30, 2024 | -19.86M |
| March 31, 2024 | -9.789M |
| December 31, 2023 | -11.15M |
| September 30, 2023 | -8.956M |
| June 30, 2023 | -7.321M |
| March 31, 2023 | -9.623M |
| December 31, 2022 | -9.94M |
| September 30, 2022 | -14.50M |
| June 30, 2022 | -10.51M |
| March 31, 2022 | -8.636M |
| December 31, 2021 | -4.11M |
| September 30, 2021 | -8.838M |
| June 30, 2021 | 0.242M |
| March 31, 2021 | -9.435M |
| December 31, 2020 | -15.03M |
| Date | Value |
|---|---|
| September 30, 2020 | -7.321M |
| June 30, 2020 | -9.765M |
| March 31, 2020 | -50.70M |
| December 31, 2019 | -22.74M |
| September 30, 2019 | -8.977M |
| June 30, 2019 | -5.478M |
| March 31, 2019 | -5.105M |
| December 31, 2018 | -13.05M |
| September 30, 2018 | -7.069M |
| June 30, 2018 | -6.244M |
| March 31, 2018 | -7.431M |
| December 31, 2017 | -1.064M |
| September 30, 2017 | -6.596M |
| June 30, 2017 | -5.007M |
| March 31, 2017 | -5.175M |
| December 31, 2016 | -4.933M |
| September 30, 2016 | -5.928M |
| June 30, 2016 | -5.172M |
| March 31, 2016 | -5.813M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Hypertension Diagnostics, Inc. | -- |
| Avitar, Inc. | -- |
| Abbott Laboratories | 920.00M |
| AngioDynamics, Inc. | -7.097M |
| Alphatec Holdings, Inc. | -5.471M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 13.78M |
| Total Expenses (Quarterly) | 36.34M |
| EPS Diluted (Quarterly) | -12.14 |